chr19-7439985-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001367823.1(ARHGEF18):c.968-359T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000971 in 1,547,440 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00090 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00098 ( 4 hom. )
Consequence
ARHGEF18
NM_001367823.1 intron
NM_001367823.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0960
Genes affected
ARHGEF18 (HGNC:17090): (Rho/Rac guanine nucleotide exchange factor 18) Rho GTPases are GTP binding proteins that regulate a wide spectrum of cellular functions. These cellular processes include cytoskeletal rearrangements, gene transcription, cell growth and motility. Activation of Rho GTPases is under the direct control of guanine nucleotide exchange factors (GEFs). The protein encoded by this gene is a guanine nucleotide exchange factor and belongs to the Rho GTPase GEF family. Family members share a common feature, a Dbl (DH) homology domain followed by a pleckstrin (PH) homology domain. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Nov 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 19-7439985-T-A is Benign according to our data. Variant chr19-7439985-T-A is described in ClinVar as [Benign]. Clinvar id is 715866.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-7439985-T-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0009 (137/152156) while in subpopulation NFE AF= 0.000912 (62/67978). AF 95% confidence interval is 0.00073. There are 2 homozygotes in gnomad4. There are 66 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGEF18 | NM_001367823.1 | c.968-359T>A | intron_variant | ENST00000668164.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGEF18 | ENST00000668164.2 | c.968-359T>A | intron_variant | NM_001367823.1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000908 AC: 138AN: 152038Hom.: 2 Cov.: 31
GnomAD3 genomes
AF:
AC:
138
AN:
152038
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00149 AC: 231AN: 154608Hom.: 2 AF XY: 0.00152 AC XY: 125AN XY: 82100
GnomAD3 exomes
AF:
AC:
231
AN:
154608
Hom.:
AF XY:
AC XY:
125
AN XY:
82100
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000978 AC: 1365AN: 1395284Hom.: 4 Cov.: 39 AF XY: 0.00107 AC XY: 738AN XY: 687806
GnomAD4 exome
AF:
AC:
1365
AN:
1395284
Hom.:
Cov.:
39
AF XY:
AC XY:
738
AN XY:
687806
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000900 AC: 137AN: 152156Hom.: 2 Cov.: 31 AF XY: 0.000887 AC XY: 66AN XY: 74392
GnomAD4 genome
AF:
AC:
137
AN:
152156
Hom.:
Cov.:
31
AF XY:
AC XY:
66
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at